safe glp 1 Comparing Ozempic, Wegovy and Other GLP-1 Drugs Types of GLP-1 Medications for

Prices vary because the brands available, doses, and pharmacy providers are not the same

In 2025, Ozempic was approved by the US Food and Drug Administration (FDA) to reduce the risk of worsening kidney disease and kidney failure in people with type 2 diabetes

Michetti, Lausanne (Gastroentrologie)

7.2 mg) to approach similar efficacy at a lower overall cost Mounjaro may be more suitable if: You want the highest likelihood of greater weight loss at standard doses You have not achieved adequate results with semaglutide-based treatments You have type 2 diabetes alongside obesity , where its dual mechanism may offer added metabolic benefits You prefer greater dosing flexibility , with six dose increments allowing more tailored titration Is It Worth Switching From Wegovy to Mounjaro